FDA Approves Unknown Drug — AMNEAL PHARMS

# FDA Approves Generic Drug Application for Amneal Pharmaceuticals Amneal Pharmaceuticals received FDA approval for ANDA210040 on December 22, 2017, expanding its generic pharmaceutical portfolio and positioning the company to capture market share in an additional therapeutic category. The approval strengthens Amneal's competitive standing in the generic drug market and provides physicians and patients with additional treatment options at lower cost points.